Clinical Trials Browser

Phase 2 × Glioblastoma × Karnofsky Performance Status × Clear all

NCT02663271 2022-06-23

TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma

Phase 2 Terminated

10 enrolled 13 charts

Glioblastoma, Glioma